Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where a protected amine functionality is required. The tert-butyl carbamate group acts as a protecting group for the amine, allowing selective reactivity in multi-step syntheses. Its structure, featuring both cyclopropyl and aminoethyl components, makes it valuable in medicinal chemistry for constructing drug candidates targeting central nervous system disorders and metabolic diseases. Commonly employed in research settings for optimizing bioavailability and stability of amine-containing molecules.